Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Jelliffe

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The American Journal of Cardiology|June 1, 2014
Concerning antiplatelet therapyRoger Jelliffe
Clinical Pharmacokinetics|May 8, 2015
Optimal methodology is important for optimal pharmacokinetic studies, therapeutic drug monitoring and patient careRoger Jelliffe
Critical Care Research and Practice|September 20, 2016
Comment on "Management of Atrial Fibrillation in Critically Ill Patients"Roger Jelliffe
American Journal of Nephrology|August 10, 2002
Estimation of creatinine clearance in patients with unstable renal function, without a urine specimenRoger Jelliffe
Journal of Clinical Pharmacology|September 25, 2008
Estimation of creatinine clearanceRoger Jelliffe
Clinical Pharmacokinetics|February 26, 2016
Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients: Is Augmented Renal Clearance What We Really Want to Know? Some Suggested Management Approaches and Clinical Software ToolsRoger Jelliffe
Therapeutic Drug Monitoring|May 20, 2020
The New Direct-Acting Oral Anticoagulants Need to be Monitored!Roger Jelliffe, Uwe Christians
The AAPS Journal|February 28, 2018
New Perspectives in Clinical Pharmacokinetics-1: the Importance of Updating the Teaching in Pharmacokinetics that both Clearance and Elimination Rate Constant Approaches Are Mathematically Proven Equally ValidRoger Jelliffe, David Bayard
Journal of Clinical Pharmacology|July 19, 2008
Practical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimizationMichael Neely, Roger Jelliffe
Journal of Clinical Pharmacology|February 16, 2010
Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometricianMichael Neely, Roger Jelliffe
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The American Journal of Cardiology|June 1, 2014
Concerning antiplatelet therapyRoger Jelliffe
Clinical Pharmacokinetics|May 8, 2015
Optimal methodology is important for optimal pharmacokinetic studies, therapeutic drug monitoring and patient careRoger Jelliffe
Critical Care Research and Practice|September 20, 2016
Comment on "Management of Atrial Fibrillation in Critically Ill Patients"Roger Jelliffe
American Journal of Nephrology|August 10, 2002
Estimation of creatinine clearance in patients with unstable renal function, without a urine specimenRoger Jelliffe
Journal of Clinical Pharmacology|September 25, 2008
Estimation of creatinine clearanceRoger Jelliffe
Clinical Pharmacokinetics|February 26, 2016
Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients: Is Augmented Renal Clearance What We Really Want to Know? Some Suggested Management Approaches and Clinical Software ToolsRoger Jelliffe
Therapeutic Drug Monitoring|May 20, 2020
The New Direct-Acting Oral Anticoagulants Need to be Monitored!Roger Jelliffe, Uwe Christians
The AAPS Journal|February 28, 2018
New Perspectives in Clinical Pharmacokinetics-1: the Importance of Updating the Teaching in Pharmacokinetics that both Clearance and Elimination Rate Constant Approaches Are Mathematically Proven Equally ValidRoger Jelliffe, David Bayard
Journal of Clinical Pharmacology|July 19, 2008
Practical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimizationMichael Neely, Roger Jelliffe
Journal of Clinical Pharmacology|February 16, 2010
Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometricianMichael Neely, Roger Jelliffe
Pageof 3